Rina Bardin supports clients with research and analysis that span a variety of healthcare sectors and stakeholders.

She applies her background in health policy research to support clients with clinical practice guideline development and patient-engagement and shared decision-making initiatives.

Prior to joining Avalere, Rina supported the outreach efforts of the Global Health Advocacy team at the United Nations Foundation where she conducted qualitative research on topics such as constituent access to care and UN-sponsored maternal health programs. Additionally, she served as a teaching assistant for undergraduate public health students on current global health challenges.

Rina has a BA in health policy with a minor in art history from the University of Rochester.

Authored Content


With support from the Robert Wood Johnson Foundation, Avalere assesses opportunities to normalize cost-of-care conversations through measurement.

Avalere is releasing a new research agenda to guide evidence generation for health system models of care that advance the intersection of social and clinical needs of Medicaid-eligible individuals.

Avalere’s issue brief highlights real-world examples of how cost of care can be woven into physician-patient conversations and how it can improve dialogues.

Avalere published an abstract in the online Journal of National Comprehensive Cancer Network (JNCCN).

Avalere’s “Preparation for Shared Decision-Making” (PFSDM) tool aims to help patients with advanced breast cancer (ABC) feel prepared to communicate with their clinicians and engage in decision making aligned with their preferences. The validation study confirms the acceptability and usability of the tool for women with ABC.

New analysis from Avalere finds the proposed case-mix adjustment for the radiation oncology model underestimates payments for prostate cancer .

Avalere served as the document manager for the 2019 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Primary Prevention of Cardiovascular Disease, released on March 17 at the ACC.19 Scientific Session. This guideline includes practical and concise evidence-based guidance for clinicians on the primary prevention of cardiovascular disease (CVD).